Molecular Partners AG Sponsored ADR (MOLN) vs Minerva Neurosciences, Inc (NERV)

Molecular Partners AG Sponsored ADR and Minerva Neurosciences, Inc are both Biotechnology companies. Molecular Partners AG Sponsored ADR and Minerva Neurosciences, Inc are of similar size ($164.7M and $160.5M). Across the 7 metrics below, Molecular Partners AG Sponsored ADR leads on 4 and Minerva Neurosciences, Inc on 3.

Valuation

Metric MOLN NERV Biotechnology median
P/E n/m n/m 7.88
P/S 28.96 n/m 11.47
P/B 2.21 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 13.74 n/m 10.73
Earnings yield (40.52%) (834.41%) (28.84%)
Free cash flow yield (35.09%) (16.59%) (23.03%)

Profitability

Metric MOLN NERV Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (63.89%) 322.05% (57.72%)
Return on assets (52.73%) (629.71%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MOLN NERV Biotechnology median
Revenue growth (TTM) (27.99%) — 5.64%
EPS growth (last fiscal year) (9.94%) (18,347.37%) —
Revenue growth, 5-year CAGR (23.12%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MOLN NERV Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.27 20.14 4.73
Net debt to EBITDA 1.66 5.46 0.96

Dividend

Metric MOLN NERV Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric MOLN NERV Biotechnology median
Market cap 160.52m 164.73m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack